Fundai

Darou Pakhsh Pharmaceutical Factories (DARU) income statement

Operating revenue through to net profit and earnings per share

Ticker
DARU
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/06/31
Operating revenue131,604,50135,704,55714,651,80822,357,32714,753,58012,281,682
Cost of operating revenue-44,610,358-19,167,706-10,215,403-14,589,988-9,305,593-6,674,454
Gross profit (loss)86,994,14316,536,8514,436,4057,767,3395,447,9875,607,228
Selling, general and administrative expenses-1,580,109-1,156,071-520,537-469,774-352,230-268,755
Other income453,952123,558103,309123,560151,38987,862
Other expenses-229,941-206,637-16,480-48,260-51,949-15,456
Operating profit (loss)85,638,04515,297,7014,002,6977,372,8655,195,1975,410,879
Finance costs-6,655,760-2,563,141-2,391,113-2,179,377-1,503,502-1,278,073
Other non-operating income and expenses356,27648,7198,45950,76499,59027,939
Profit (loss) from continuing operations before tax79,338,56112,783,2791,620,0435,244,2523,791,2854,160,745
Current year tax-18,237,434-2,941,815-364,403-1,205,524-870,248-948,890
Net profit (loss) from continuing operations60,190,2578,528,1091,104,8603,700,6242,870,7323,197,251
Net profit (loss)60,190,2578,528,1091,104,8603,700,6242,870,7323,197,251
Basic earnings (loss) per share1,163 rials165 rials425 rials1,424 rials1,917 rials2,141 rials
Net earnings (loss) per share, rials1,162 rials165 rials425 rials1,424 rials1,914 rials2,132 rials
Capital51,800,00051,800,0002,600,0002,600,0001,500,0001,500,000

Reporting periods

92 periods are on file for this report, from the period ending 1380/12/29 to the period ending 1405/06/31.